HKAM
DCOY

Horizon Kinetics Asset Management’s Decoy Therapeutics DCOY Stock Holding History

Horizon Kinetics Asset Management’s Portfolio DCOY Stock Details DCOY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-22
Closed -$16.4K – 332
2024
Q1 		$16.4K Hold
22
– – ﹤0.01% 322
2023
Q4 		$20.2K Sell
22
-1
-4% -$998 ﹤0.01% 321
2023
Q3 		$21.3K Hold
23
– – ﹤0.01% 324
2023
Q2 		$48.3K Hold
23
– – ﹤0.01% 323
2023
Q1 		$61.9K Buy
+23
New +$74K ﹤0.01% 322
2022
Q4 		– Sell
-2
Closed -$12K – 345
2022
Q3 		$12K Buy
2
+1
+100% +$7.56K ﹤0.01% 328
2022
Q2 		$8K Buy
+1
New +$8.63K ﹤0.01% 336

Other funds holding DCOY

AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return